ImmuPharma Plc

(LSE) IMM

Current Price$4.14

Market Cap$2.53B

Since IPO (2006)-92%

5 Year-54%

1 Year+19%

1 Month-18%

ImmuPharma Plc Financials at a Glance

Market Cap

$2.53B

Revenue (TTM)

$0.00

Net Income (TTM)

$3.93M

EPS (TTM)

$-0.89

P/E Ratio

-4.55

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Price

$4.14

Volume

1,373,279

Open

$4.20

Price

$4.14

Volume

1,373,279

Open

$4.20

Previous Close

$4.14

Daily Range

$4.01 - $4.38

52-Week Range

$1.39 - $19.33

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Price

$4.14

Volume

1,373,279

Open

$4.20

Previous Close

$4.14

Daily Range

$4.01 - $4.38

52-Week Range

$1.39 - $19.33

IMM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImmuPharma Plc

Industry

Pharmaceuticals

Sector

Health Care

CEO

Tim McCarthy McCarthy, MBA

Website

www.immupharma.com

Headquarters

London, EC1A 7BL, GB

IMM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-260%

Return on Capital

-10%

Return on Assets

-2%

Earnings Yield

-21.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.53B

Shares Outstanding

623.91M

Volume

1.37M

Avg. Volume

3.01M

Financials (TTM)

Gross Profit

$63.88K

Operating Income

$2.28M

EBITDA

$2.61M

Operating Cash Flow

$1.77M

Capital Expenditure

$1.65K

Free Cash Flow

$1.77M

Cash & ST Invst.

$236.90K

Total Debt

$0.00

ImmuPharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$28.52K

-51.4%

Gross Margin

0.00%

N/A

Market Cap

$2.53B

N/A

Market Cap/Employee

$505.37M

N/A

Employees

N/A

Net Income

$919.44K

-373.9%

EBITDA

$600.65K

-4.9%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$396.65K

-63.4%

Accounts Receivable

$155.37K

-55.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.83%

N/A

Return on Invested Capital

-10.00%

N/A

Free Cash Flow

$502.57K

-14.6%

Operating Cash Flow

$502.57K

-14.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPEC.LINSPECS Group plc

SPEC.LINSPECS Group plc$83.50+0.00%

EAH.LECO Animal Health Group plc

EAH.LECO Animal Health Group plc$93.50+0.54%

CREO.LCreo Medical Limited

CREO.LCreo Medical Limited$12.63-2.88%

HVO.LhVIVO plc

HVO.LhVIVO plc$7.30-2.67%

KOO.LKooth plc

KOO.LKooth plc$128.50+0.00%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc$676.50+0.22%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC$4.30-3.37%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About IMM

What is the current price of ImmuPharma Plc?

ImmuPharma Plc is trading at GBX 4.14 per share.

What is the 52-week range for ImmuPharma Plc?

Over the past 52 weeks, ImmuPharma Plc has traded between GBX 1.39 and GBX 19.33.

How much debt does ImmuPharma Plc have?

As of the most recent reporting period, ImmuPharma Plc reported total debt of N/A.

How much cash does ImmuPharma Plc have on hand?

ImmuPharma Plc reported $236,902 in cash and cash equivalents in its most recent financial results.

What is ImmuPharma Plc’s dividend yield?

ImmuPharma Plc does not currently have a dividend yield.

ImmuPharma Plc

ImmuPharma Plc Financials at a Glance

IMM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ImmuPharma Plc

IMM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ImmuPharma Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMM

What is the current price of ImmuPharma Plc?

What is the 52-week range for ImmuPharma Plc?

How much debt does ImmuPharma Plc have?

How much cash does ImmuPharma Plc have on hand?

What is ImmuPharma Plc’s dividend yield?

Premium Investing Services